By proceeding, you agree to our Terms of Use and Privacy Policy.
Global Head, HEOR, HTA & RWE; and Head, Value & Access, Pipeline Franchise
#healtheconomics #outcomesresearch #marketaccess
#NorthAmerica
Charles Makin is a distinguished expert adept at harmonizing rigorous scientific methodology with strategic business insight to craft, showcase, and disseminate the value and real-world efficacy of ph
Chief Operating Officer, Population Health
#valuebasedcare #healtheconomics #populationhealth #healthinformatics #artificialintelligence
Deepak serves as Senior Vice President of Value Based Care & Population Health Informatics at Providence. He is leading system-wide transformation from fee for service to value based payment models. I
VP, Global Head of Market Access: Cell and Gene Therapies + Digital Health
#Marketaccess #Healtheconomics
#Northamerica
Experienced senior leader with a track record of building global and local teams to deliver innovative market access solutions; Passion for developing talent and high-performing teams; In-depth knowle
Associate Director, Data and Analytics Centre of Excellence
#quantitativeresearch #healtheconomics #statisticalmodeling
Josian Edmond's journey in healthcare analytics began over a decade ago in a small graduate health economics class on the eastern coast of Canada. Since that pivotal moment, he has accumulated more th
Head of Market Access
#marketaccess #healtheconomics
#Europe
Professional in expanding market access, and government affairs focusing on the pharmaceutical and healthcare access for more than 15 years.
Senior Director, Head of Health Economics & Outcomes Research International & Japan
#healtheconomics
Karl-Johan Myren is currently Senior Director, Head of Health Economics & Outcomes Research International & Japan at Alexion Pharmaceuticals, Inc.
Professor
#eib #mentoring #womenshealth #healtheconomics #thoughtsonthursday
Dr. Kevin Frick is a professor at the Johns Hopkins Carey Business School with joint appointments in the Bloomberg School of Public Health and the School of Medicine. He has a longstanding interest i
Executive Director and Head, HTA Statistics
#epidemiology #healtheconomics
Lara Wolfson is currently working as Executive Director and Head, HTA Statistics at Merck.
Value & Access Policy Director
#healtheconomics #strategicpricing
Paul has worked in the healthcare, local government and pharmaceutical sectors for over 30 years.
Associate Professor and Director
#healtheconomics #epidemiology
Pierre is currently working as a Associate Professor and Director at Florida Atlantic University
Director, Global Health Economics and Outcomes Research
Samuel Hong is a Director of Global Health Economics and Outcomes Research (HEOR) in the Diagnostics and Genomics Group at Agilent Technologies.
Head of Access and Policy
#healtheconomics #pharmaceuticalindustry #marketaccess
Dynamic, versatile, and accomplished negotiator, Sophie is recognized for her leadership and problem-solving skills. Graduate and postgraduate studies in health economics are combined with her experie